Immune homeostasis is essential for the normal functioning of the immune system, and its breakdown leads to fatal inflammatory diseases. We report here the identification of a member of the tumor necrosis factor-a-induced protein-8 (TNFAIP8) family, designated TIPE2, that is required for maintaining immune homeostasis. TIPE2 is preferentially expressed in lymphoid tissues, and its deletion in mice leads to multiorgan inflammation, splenomegaly, and premature death. TIPE2-deficient animals are hypersensitive to septic shock, and TIPE2-deficient cells are hyper-responsive to Toll-like receptor (TLR) and T cell receptor (TCR) activation. Importantly, TIPE2 binds to caspase-8 and inhibits activating protein-1 and nuclear factor-kB activation while promoting Fas-induced apoptosis. Inhibiting caspase-8 significantly blocks the hyper-responsiveness of TIPE2-deficient cells. These results establish that TIPE2 is an essential negative regulator of TLR and TCR function, and its selective expression in the immune system prevents hyperresponsiveness and maintains immune homeostasis.
INTRODUCTION
The immune system is frequently bombarded by large quantities of foreign antigens. Upon engaging these antigens through specific receptors, the immune system mounts specific responses characterized by immune cell activation, proliferation, and inflammatory gene expression, all of which in turn lead to inflammation. Upon removal of the antigen, the immune system returns to its preactivation state, ready to respond to new antigens. The strength and the duration of the immune responses must be tightly regulated because uncontrolled inflammation can cause severe tissue injury and death of the organism. Immune homeostasis is the inherent property of the immune system to maintain a constant number of immune cells and to prevent deleterious inflammatory responses despite frequent stimulations by antigens. It ensures that any antigen-precipitated change of the immune system is kept to the minimum so that the immune responses eliminate the antigen in question but do not lead to fatal inflammatory diseases (Van Parijs and Abbas, 1998) . The molecular mechanisms through which immune homeostasis is maintained are not fully understood, but recent studies indicate that at least two classes of molecules are required. The first class includes molecules that limit the strength of immune cell activation and expansion. These include inhibitory cytokines (such as transforming growth factor [TGF]-b and interleukin [IL]-10), negative regulators of the antigen receptor and Toll-like receptor (TLR) signaling (such as CTLA-4, inhibitor-of-kB, Socs1, and itch), and repressive transcription factors (such as Foxp3) (Van Parijs and Abbas, 1998; Wahl et al., 2006) . The second class controls cell death, which includes Fas, Bim, Bax, and the caspases -8 and -10 ( Nagata and Suda, 1995; Van Parijs and Abbas, 1998) . When these molecules are depleted from the immune system, immune homeostasis fails and severe inflammatory diseases ensue, which in turn lead to premature death of the organism (Van Parijs and Abbas, 1998) . Because a large number of genes in the mammalian genomes have not yet been characterized, the number and identity of additional genes required for maintaining immune homeostasis are unknown.
Tumor necrosis factor (TNF)-a-induced protein 8 (TNFAIP8)-also known as SCC-S2, GG2-1, and MDC-3.13-is a recently identified apoptosis regulator (Kumar et al., , 2004 Patel et al., 1997; Yoshinaga-Hirabayashi and Yoneda, 2001; Zhang et al., 2006) . Like several other regulators/mediators of apoptosis, TNFAIP8 contains a death effector domain (DED) and is able to inhibit caspase-mediated apoptosis . Knocking down TNFAIP8 expression in tumor cells reduces their tumorigenicity suggesting that it may play a role in oncogenesis (Zhang et al., 2006) . However, the physiological role of TNFAIP8 is not clear. In an attempt to identify genes that regulate inflammation and immune homeostasis, we analyzed the transcriptome of murine spinal cord before and after the development of autoimmune encephalomyelitis, using a highthroughput gene microarray technology. We identified more than 100 genes that are highly expressed in inflamed but not normal nervous tissue (Carmody et al., 2002) . One of these genes shares a high degree of sequence homology with TNFAIP8, which we call TIPE2. Using knockout, knockdown, and gain-of-function approaches, we established that TIPE2 is a negative regulator of immune cell function, required for preventing hyperresponsiveness and maintaining immune homeostasis.
RESULTS

Identification of a New Member of the TNFAIP8 Family from Inflamed Spinal Cord
To isolate new genes involved in autoimmune inflammation, we used Affymetrix gene chips to examine gene expression profiles of murine spinal cords before and after the development of experimental autoimmune encephalomyelitis (EAE) (Carmody et al., 2002) . This led to the identification of 141 genes that were highly expressed in the inflamed spinal cord but totally absent in normal spinal cord (Carmody et al., 2002) . One of these genes was represented in the gene bank as the expressed sequence tag (EST) AI847688. By aligning this EST against the mouse EST database in the gene bank using the BLAST sequence homology search program, we identified a putative full-length cDNA, designated TIPE2 TNFAIP8-like 2, with a predicted open reading frame encoding 184 amino acids ( Figure S1A ). By aligning this sequence against the human EST database in the gene bank using the same BLAST program, we identified a putative TIPE2 human homolog that shares 94% amino acid sequence identity with murine TIPE2 (Figure S1A ). Human TIPE2 shares approximately 53% identity and 78% similarity with TNFAIP8 . Additionally, TIPE2 contains a putative DED-like domain that shows significant identity/similarity to other known DED sequences ( Figure S1B ). The identity/similarity shared between DED of murine TIPE2 and those of the following proteins are as follows: TNFAIP8, 50%/73%; murine cFLIP (FADD-like interleukin-1b-converting enzyme inhibitory protein) DED I, 19%/32%; murine cFLIP DED II, 13%/33%; murine caspase-8 DED I, 19%/40%; and murine caspase-8 DED II, 20%/38%. The TIPE2 DED domain resides in its NH 2 -terminal region ( Figure S1 ). Like other DED-containing proteins, TIPE2 also possesses six putative conserved a helices as determined by NPS Network Protein Sequence Analysis (Combet et al., 2000) . Besides TIPE2, two additional members of the TNFAIP8 family may exist, which share high degrees of sequence homology with TIPE2 and are designated in the gene bank as TNFAIP8L1 (TIPE1) and TNFAIP8L3 (TIPE3). Thus, the TNFAIP8 family may consist of at least four members.
The chromosome location of TIPE2 was then determined by aligning the murine and human TIPE2 sequences with murine and human genome databases, respectively. A single locus was identified for murine TIPE2 on chromosome III (3f1-3f3) and for human TIPE2 on chromosome I (1q21.2-1q21.3).
Preferential Expression of TIPE2 in Lymphoid and Inflamed Tissues
To determine the expression pattern of TIPE2, total RNA was extracted from tissues of perfused normal and EAE mice, fractionated by electrophoresis, and transferred to a Hybond-N nylon membrane. The RNA was then hybridized with the full-length TIPE2 cDNA probe. A $1.1 kb transcript was detected in the thymus, spleen, lymph node, and small intestine, but not in the liver, heart, muscle, testis, spinal cord, or brain of normal mice. By contrast, high levels of TIPE2 mRNA were detected in the spinal cord of mice with EAE ( Figure 1A ). Furthermore, a weak TIPE2 signal was also detected in the lung, skin and colon, which all contain lymphoid tissues. Therefore, TIPE2 detected in the inflamed spinal cord is likely expressed by infiltrating cells of the immune system.
To determine which cell type expresses TIPE2, we performed northern blot and/or PCR analysis of a panel of cell preparations ( Figures 1B-1E ). We found that macrophages, B, and T lymphocytes of various developmental stages, constitutively expressed TIPE2 ( Figures 1C and S2) . One of the two T cell lines (EL-4) and two of the macrophage cell lines (RAW 264.7 and Wehi 274.1) expressed TIPE2. By contrast, neither NIH 3T3 fibroblasts nor myeloma cell lines (SP2/0 and OKT3) constitutively expressed TIPE2. However, following stimulation with TNF-a, NIH 3T3 fibroblasts expressed detectable levels of TIPE2 mRNA ( Figure 1E ). Thus, TIPE2 is preferentially expressed by lymphoid and myeloid cells but may be induced in other cell types by TNF-a.
Spontaneous Development of Fatal Inflammatory Diseases in TIPE2-Deficient Mice
To elucidate the roles of TIPE2 in vivo, we generated TIPE2-deficient mice by deleting both exons of the TIPE2 gene through homologous recombination ( Figure S3 ). The TIPE2 mRNA is completely absent in mice homozygous for the gene mutation ( Figure S3C ). Mice homozygous for the TIPE2 gene mutation developed normally and were born with the expected Mendelian ratio. However, starting from approximately 2 months of age, many TIPE2 À/À mice became chronically ill, characterized by body weight loss, splenomegaly, leukocytosis, and multiorgan inflammation. By the end of month 11, $50% of TIPE2 À/À mice died of the disease (Figure 2A ). Histological examinations revealed severe mononuclear cell infiltration in multiple organs including lung ( Figure 2D ), liver, and intestine starting approximately 3 months after the birth. The splenic microarchitecture was also destroyed due to the enlargement of the white pulps. Serological testing showed high levels of inflammatory cytokines such as IL-1, IL-6, IL-12, and TNF-a as well as the inhibitory cytokine IL-10 in the blood of TIPE2 À/À but not TIPE2 +/+ mice ( Figure 2B ).
By contrast, the total amounts of immunoglobulin (Ig) of various isotypes remained largely unchanged in 4-month-old TIPE2 À/À mice with the exception of IgG2a and IgG2b, which were reduced as compared to those of control littermates ( Figure S4 ). À/À mice. As further discussed below, this dichotomy is likely due to the receptor-specific-but not cell-specific-functions of TIPE2.
In vitro, purified TIPE2 À/À T cells were hyperreactive to T cell receptor (TCR) ligation and produced significantly higher levels of Th17 cytokines as compared to WT controls ( Figure 4D ). The production of Th1 cytokine IFN-g and Th2 cytokine IL-4 was also increased to various degrees in TIPE2 À/À cultures, but no significant changes in T cell proliferation were apparent. In addition to cytokines, CD25, CD44, and CD69 expression was also higher in TIPE2 knockout T cells activated in Figure 4D . Specifically, the percentages of T cells that expressed CD25, CD44, and CD69 at the end of the culture increased from 60 ± 12, 50 ± 11 and 64 ± 11 in the wild-type group to 87 ± 1.4, 72 ± 2 and 90 ± 1.1 in the knockout group, respectively (p < 0.02) ( Figure S6 ). Cells used in these experiments were from 4-to 5-week-old mice that did not have detectable inflammatory diseases or increased numbers of CD69 + activated cells.
These results indicate that TIPE2 may negatively regulate T cell activation. To further test this theory, we utilized a retrovirus-mediated gene transfer system that allows stable TIPE2 gene transfer into hematopoietic cells. We found that the expression of the activation marker CD69 and cytokine IFN-g was significantly reduced in cells overexpressing TIPE2 following stimulation with the specific antigen ( Figure S7 ). This was accompanied by a small but detectable reduction in the activation marker CD44 expression in these cells ( Figure S7 ). Furthermore, cell division was also reduced in cells overexpressing TIPE2, indicating that TIPE2 may regulate mitosis under certain conditions. Taken together, these results indicate that TIPE2 is able to inhibit TCR-mediated T cell activation.
Hypersensitivity of TIPE2 Knockout and Knockdown Cells to Toll-like Receptor Stimulation
To determine the potential roles of TIPE2 in innate immune responses to TLR ligands, we studied TIPE2 knockout and knockdown cells in vitro. Upon stimulation with lipopolysaccharide (LPS), bone marrow-derived TIPE2 À/À macrophages produced significantly more IL-6 and IL-12 than wild-type cells, with relatively normal amounts of TNF-a ( Figure 5A ). Similarly, knocking down TIPE2 expression in the RAW 264.7 macrophages significantly increased the levels of IL-6 protein ( Figure 5C ) and mRNA ( Figure 5D ). The effect of TIPE2 knockdown is not limited to LPS because responses to three additional TLR ligands were also significantly increased in the knockdown macrophages ( Figure 5E ).
Furthermore, TIPE2 À/À splenic B cells expressed significantly more IL-1b and TNF-a than wild-type B cells upon stim- Figure S4 ). It is to be noted that TNF-a is significantly affected by TIPE2 deficiency in B cells but not in macrophages treated with TLR ligands. This indicates that TIPE2 may regulate TNF-a expression in a cell-specific manner. Differences between B cells and macrophages in their usage of transcription factors and signaling molecules are likely responsible for this cell-specific effect of TIPE2 on TNF-a.
Hypersensitivity of TIPE2 Knockout Mice to Septic Shock
If TIPE2 deficiency enhances TLR activation, will it subject mice to septic shock? To address this question, we studied LPS-induced sepsis in mice that were injected with a low-dose LPS. We found that septic shock was dramatically accelerated and exacerbated in TIPE2 À/À mice as compared to wild-type controls. This was reflected by a sharp decline in the survival rate (0% versus 91%), a significant increase in seral IL-1b, IL-6, and IL-12p40 (Figure 6 ), and severe multiorgan necrosis in TIPE2 À/À mice (data not shown). Because mice used in these experiments were only 5 to 6 weeks old, not suffering from the inflammatory syndrome described above, these data indicate that TIPE2 is directly responsible for preventing septic shock.
Negative Regulation of Activating Protein (AP)-1 and Nuclear Factor (NF)-kB Pathways by TIPE2 Most cytokines affected by TIPE2 deficiency or knockdown are targets of two major signaling pathways downstream of both TCR and TLR, i.e., the mitogen-activated protein (MAP) kinases and the NF-kB pathways. To determine whether TIPE2 regulates these two pathways, we performed biochemical analyses of key signaling molecules involved. We found that the c-Jun N-terminal kinase (JNK), p38, and the NF-kB pathway, but not the extracellular signal-regulated kinase (ERK) pathway, were targets of TIPE2 action. Specifically, TIPE2 knockdown amplified the JNK and p38 pathways at the level of AP-1 binding to DNA (Figure S9A ), c-Fos, and c-Jun nuclear translocation ( Figure 7A ), as well as JNK1/2 and p38 phosphorylation ( Figures 7A and 7B) . Similarly, TIPE2 knockdown enhanced NF-kB nuclear translocation ( Figure S10 ) and inhibitor-of-kB (IkB) phosphorylation ( Figure 7A) ; NF-kB binding to DNA was also increased in resting TIPE2 knockdown cells suggesting that TIPE2 may regulate the (A) Bone marrow-derived macrophages from wild-type and TIPE2-deficient mice (n = 5) were treated with or without LPS (100 ng/ml) for 8 hr. IL-6, IL-12p40, and TNF-a concentrations were determined by ELISA. (B) TIPE2 mRNA levels in wild-type and TIPE2 knockdown (KD) RAW 264.7 macrophages as determined by RT-PCR. GAPDH was used as a loading control whereas H 2 O was used as the background control. (C and D) Wild-type and TIPE2 knockdown RAW 264.7 cells were treated with LPS (100 ng/ml) for the indicated times. IL-6 protein (C) and mRNA (D) levels were determined by ELISA and real-time PCR, respectively. (E) Wild-type and TIPE2 knockdown RAW 264.7 cells were treated with LPS (100 ng/ml), peptidoglycans (PGN) (10 mg/ml), Poly(I:C) (50 mg/ml), or CpG oligodeoxy nucleotides (CPG) (1 mM) for 8 hr. IL-6 concentrations in the supernatants were determined by ELISA. Data shown are representative of three experiments. The p value shown is for all TLR treated WT cultures as compared to their respective TIPE2 KD groups. No significant differences were detected between the two groups in terms of the number and percentage of apoptotic cells as determined by Annexin V staining.
basal levels of the NF-kB activity ( Figure S9B ). By contrast, little or no difference in ERK activation was noted between wild-type and TIPE2 knockdown cells ( Figure 7A ). Consistent with these results, JNK and p38 activities were also significantly increased in TIPE2 knockout T cells as compared to wild-type controls ( Figure S11A ). In TIPE2 knockout macrophages, significant increases in IkBa degradation and phosphorylation were observed 15-60 min after LPS stimulation, whereas increases in JNK and p38 phosphorylation were noted only at 5 and 120 min after LPS stimulation ( Figure S11B ). No significant differences in ERK phosphorylation between wild-type and TIPE2 knockout macrophages were noted at any time points tested. Taken together, these data indicate that TIPE2 is a negative regulator of NF-kB, JNK, and p38 pathways.
Caspase-8 Interaction with Endogenous TIPE2 and Its Role in TIPE2 Function
Results discussed above indicate that the point of action of TIPE2 may lie upstream of MAPK and NF-kB pathways. Because TIPE2 has a DED-like domain and certain DED-containing proteins-such as caspase-8-regulate NF-kB activation, we hypothesized that TIPE2 might interact with these proteins. To test this theory, the HA-or FLAG-tagged TIPE2, FLAG-tagged mutant procaspase-8 (the cysteine at position 360 was replaced by serine to abolish its apoptotic activity), and FLAG-tagged Fasassociated death domain (FADD) were expressed in 293 cells (B) IL-1b, IL-6, IL-12p40, and TNF-a concentrations in the sera as determined by ELISA. For the LPS-treated group, mice were injected with LPS as in (A), and sera were collected 48 hr later. For the untreated group, sera were collected from age-and sex-matched naive mice (n = 6). Data shown are means and SD and are representative of two experiments.
following transfection with corresponding expression plasmids ( Figure S12 ). Coimmunoprecipitation analyses revealed that overexpressed TIPE2 specifically associated with overexpressed or endogenous caspase-8 but not FADD. To confirm this interaction for the endogenous TIPE2 protein, RAW 264.7 macrophage extracts were used to immunoprecipitate TIPE2-binding proteins with a specific anti-TIPE2 antibody. Upon blotting with anti-caspase-8 antibody, a strong caspase-8 signal was detected in the precipitates ( Figure 7C ). This caspase-8 signal was almost completely absent in the TIPE2 knockdown cells, confirming the specificity of the assay. By contrast, FLIP was not detected in the immunoprecipitates. Robust interactions between endogenous TIPE2 and caspase-8 were observed in both resting and LPS-stimulated RAW cells, with little detectable differences. Therefore, TLR stimulation may not be required for TIPE2 binding to caspase-8. Importantly, both FADD and caspase-8 were normally recruited to the death-inducing signaling complex (DISC) ( Figure S13 ) in TIPE2 knockdown cells following Fas ligation. Caspase-8 cleavage was also normal in these cells. By contrast, TIPE2 was not recruited to the DISC ( Figure S13) . Therefore, the target of TIPE2 action on the apoptotic pathway is likely downstream of caspase-8 or the DISC.
These results establish that TIPE2 is a caspase-8-binding protein, which may regulate caspase-8-dependent functions. In addition to inducing apoptosis, caspase-8 is also crucial for lymphocyte and myeloid cell activation, presumably through regulating the NF-kB signaling pathway (Bidere et al., 2006; Chaudhary et al., 1999; Lemmers et al., 2007; Su et al., 2005; Takahashi et al., 2006) . Blocking caspase-8 activation with a specific caspase-8 inhibitor impeded the phosphorylation of IkBa, but not that of ERK, JNK, or p38 ( Figure S14 ) (data not shown). To determine whether caspase-8 played any role in TIPE2 functioning, we blocked caspase-8 activity in wild-type and TIPE2 knockdown RAW 264.7 macrophages using the caspase-8 inhibitor. By flow cytometry, we found that caspase-8 blockade significantly diminished the hyperresponsiveness of TIPE2 knockdown cells ( Figure 7D ). Both the percentage of IL-6-producing cells and the mean fluorescence intensity of IL-6 were reduced. Significant reduction in IL-6 levels in the culture supernatants were also observed by ELISA (data not shown). These data indicate that TIPE2 may inhibit NF-kB activation by enzymatically active caspase-8 (Bidere et al., 2006; Su et al., 2005) . In addition to activated caspase-8, the prodomain of the caspase-8 precursor can also mediate NF-kB activation when overexpressed in vitro (Chaudhary et al., 2000; Hu et al., 2000) . However, we found that TIPE2 was unable to modulate NF-kB activation induced by the caspase-8 precursor ( Figure S15 ).
Regulation of Fas-Mediated Apoptosis and Activation-Induced Cell Death by TIPE2
Because caspase-8 is an apoptosis initiator, we asked whether its new binding partner, TIPE2, regulated cell death. By comparing wild-type and TIPE2 knockdown or knockout cells, we found no evidence that TIPE2 regulated cell death induced by the following agents/conditions: staurosporine, ultraviolet (UV), gamma irradiation, etoposide, LPS, CpG, TNF-a, serum or cytokine deprivation, and cell culture conditions described in previous experiments (Figures 7E and S16) (data not shown). However, a role for TIPE2 in T cell death was detected under two experimental conditions. The first was the activationinduced cell death (AICD) assay in which T cells were repeatedly stimulated with anti-CD3 antibodies. Both CD4 + and CD8 + T cell death was reduced in the absence of TIPE2 ( Figure 7F ). The second was the Fas ligand (FasL)-induced apoptosis of the T cell line EL-4. In the absence of FasL, wild-type and TIPE2 knockdown EL-4 cells underwent similar degrees of spontaneous apoptosis. By contrast, FasL-induced apoptosis was significantly blocked in TIPE2 knockdown cells ( Figure 7G ). Consistent with this result, overexpressing TIPE2 in EL-4 cells significantly enhanced FasLinduced apoptosis ( Figure S17 ). As discussed below, because TIPE2 is not recruited to the DISC, the reduced apoptosis in TIPE2 knockout and knockdown cells is likely secondary to its effect on cell activation.
DISCUSSION
Results reported here indicate that TIPE2 is an essential negative regulator of inflammation and immune homeostasis. TIPE2-deficient mice suffer from chronic inflammatory diseases, and TIPE2-deficient T cells and macrophages produce significantly increased levels of inflammatory cytokines. The inflammatory disease in TIPE2-deficient mice shares many similarities with those of mice and/or humans deficient in fas/fasl, caspase-8, caspase-10, bim, ctla4, tgfb, il2, il10, Ikb, socs1, itch, and foxp3 (Chun et al., 2002; Van Parijs and Abbas, 1998; Wahl et al., 2006) . This indicates that immune homeostasis is maintained by multiple negative regulators that could not compensate for each other, because deficiency in any one of them leads to fatal inflammatory diseases. Since $30% of genes in the murine and human genomes have not yet been studied, the total number of genes required for maintaining immune homeostasis remains to be determined.
TIPE2 in TCR and TLR Signaling
Results reported here indicate that TIPE2 is a critical regulator of both TCR and TLR signaling. TCR and TLR initiate immune responses by transmitting receptor-proximal signals into immune cells through well-organized signaling complexes, or signalosomes, which consist of both common and receptor-specific signaling molecules. The receptor-proximal signals culminate in the activation of several transcription factors, which include AP-1 and NF-kB. These transcription factors in turn activate genes that mediate the activation, differentiation, and effector functions of immune cells. Results reported here suggest that TIPE2 regulates TCR and TLR signaling by targeting-at least in part-signaling complexes that contain caspase-8. Although best known as an apoptosis initiator down-stream of death receptors, caspase-8 has recently been shown to play essential roles in immune cell activation and proliferation. Caspase-8 deficiency in humans and mice not only blocks death receptor-induced apoptosis but also leads to immune deficiency (Chun et al., 2002; Salmena and Hakem, 2005) . Caspase-8-deficient immune cells are defective in their responses to both TLR and antigen receptor stimulations (Bidere et al., 2006; Chun et al., 2002; Lemmers et al., 2007; Salmena and Hakem, 2005; Su et al., 2005; Takahashi et al., 2006) . The effect of caspase-8 on cell activation is independent from its role in apoptosis but may require NF-kB activation mediated by the activation receptor-induced signalosome (ARIS) that contains CARMA1, Bcl10, MALT1, and IKK (inhibitor of kB kinase) (Bidere et al., 2006; Lemmers et al., 2007; Su et al., 2005) . Although the precise mechanism(s) through which caspase-8 activates NF-kB is/are not clear, two theories have been put forward. The first may be called ''the prodomain theory,'' which states that the prodomain of the caspase-8 precursor recruits other components of the ARIS to activate IKK (Chaudhary et al., 2000; Hu et al., 2000) . This theory is supported primarily by experiments in which caspase-8 is overexpressed. The second may be called ''the active caspase theory,'' which states that the enzymatic activity of the caspase-8 (but not the prodomain) is required for its effect on IKK activation (Bidere et al., 2006; Su et al., 2005) . Data reported here provide additional support for the second theory and indicate that TIPE2 may regulate the active caspase-8-dependent-but not prodomain-dependent-NF-kB activation. Additionally, because JNK and p38 phosphorylation is also enhanced in TIPE2 À/À cells but caspase-8 inhibitors block only NF-kB (not MAP kinase activation), we further propose that TIPE2 may regulate the MAP kinase pathway through caspase-8-independent mechanisms.
(E and F) TIPE2 knockout T cells are resistant to activation-induced, but not cytokine withdrawal-induced, cell death. Splenocytes from wild-type and TIPE2 knockout mice (n = 5) were subjected to cytokine withdrawal-induced (E) or activation-induced (F) cell death as described in Experimental Procedures. The percentage of apoptotic cells was determined by flow cytometry following staining cells with Annexin V, anti-CD4, and anti-CD8 antibodies (Song et al., 2000) . While the CARMA1-MALT1-Bcl10-caspase-8-IKK signalosome is well characterized for T cells following TCR activation (Bidere et al., 2006; Su et al., 2005) , whether a similar signaling complex forms following TLR activation is not clear. It was reported that caspase-8 recruitment to the IKK complex following TLR activation in B cells could only be detected at 30 min (Lemmers et al., 2007) . Whether this occurs in macrophages is unknown. To address this issue, we performed immunoprecipitation analyses of primary murine macrophages and RAW macrophages using antibodies to caspase-8, IKKa, and IKKb. We were unable to detect any caspase-8 signal using these antibodies 0-60 min after LPS stimulation (data not shown). These results indicate that (1) the IKK-caspase-8 complex in macrophages may be unstable, or (2) IKK and caspase-8 may reside in different signalosomes in macrophages following TLR4 activation.
TIPE2 in Immune Cell Apoptosis and Homeostasis
It is a well-recognized paradox that certain DED-containing proteins are capable of regulating both apoptosis and cell activation. These include FADD (Hua et al., 2003; Hueber et al., 2000) , FLIP (Chang et al., 2002) , and caspase-8 (Su et al., 2005) . While the molecular mechanisms underlying this paradox are not fully understood, research about these molecules has led to the characterization of a central apoptotic pathway operating in a variety of cell types. This pathway is called extrinsic, death receptor-induced, or mitochondria-independent pathway of apoptosis. Unlike the intrinsic or mitochondria-dependent pathway that is activated primarily by ''stress factors'' that disrupt the integrity of the outer membrane of mitochondria, the extrinsic pathway is activated by death receptors of the TNF family (Budihardjo et al., 1999) . Both pathways of apoptosis are crucial for immune homeostasis and the normal functioning of the immune system. However, AICD of T cells, as tested in this study, relies primarily on the extrinsic pathway in which Fas plays an essential role (Kabelitz et al., 1993) . Results reported here establish that TIPE2 is involved in regulating both apoptosis and activation of T lymphocytes.
In theory, TIPE2 may regulate Fas-mediated apoptosis through two distinct mechanisms: (1) by directly modulating the activities of caspase-8 in the DISC, and (2) by altering the levels of death and survival factors that control the Fas apoptotic pathway. Because TIPE2 is not recruited to DISC upon Fas ligation ( Figure S13 ), the second, but not the first, mechanism is most likely operating in our system. In support of this, NF-kB activation is significantly enhanced in TIPE2 knockdown cells both under resting and activating conditions ( Figures 7A, S9B , and S10). Because NF-kB is an effective inhibitor of Fas-induced apoptosis (Dudley et al., 1999; Rivera-Walsh et al., 2000) , we propose that the increased NF-kB activation is responsible for the resistance of TIPE2-deficient cells to Fas-induced apoptosis. With the exception of the DED-like domain, TIPE2 and the other three members of its family do not share sequence homology with other DED-containing proteins or any other known proteins. Therefore, the TIPE2 family may represent a previously unrecognized class of apoptosis regulators.
Our data indicate that TIPE2 knockout T cells do not have an intrinsic defect in proliferation when activated in vitro with anti-CD3 and anti-CD28 ( Figure 4D ). Therefore, splenomegaly and leukocytosis in TIPE2 À/À mice are likely mediated by proliferation-independent mechanisms. These may include a resistance of immune cells to activation-induced cell death as shown in Figure 7 and chronic expansion of immune cells in vivo as a result of increased production of cytokines that promote proliferation.
In summary, we have isolated a gene from inflamed nervous tissue and discovered that it is an essential negative regulator of both innate and adaptive immunity. Understanding the basic biology of this new molecule should provide unusual insights into the mechanisms of inflammatory diseases and immune homeostasis.
EXPERIMENTAL PROCEDURES
Cloning of TIPE2 An expressed sequence tag (AI847688) was identified from a microarray analysis (Carmody et al., 2002) as one of the 141 genes preferentially expressed in inflamed but not normal spinal cord. A putative mouse full-length sequence was generated by aligning the EST sequence with the mouse EST database using the BLAST program. This gave rise to a cDNA of 555 bp (GenBank accession number AF548004). Full-length TIPE2 was then isolated from the spinal cord of mice with EAE by RT-PCR using TIPE2-specific primers. A human testis cDNA clone that bears a high degree of homology with mouse TIPE2 was identified by BLAST search of the human EST database and purchased directly from ATCC (GenBank accession number BG258888, clone number 4509736). The full-length TIPE2 was then sequenced and cloned into the expression vector pRK5 with FLAG or HA tag at the C terminus.
Northern Blot
Total RNA of cells or tissues was prepared using the Trizol reagent (GIBCOL BRL, Carlsbad, CA), fractionated by electrophoresis, transferred to a nylon membrane, and hybridized at 60 C with 32 P-labeled DNA probes specific for TIPE2 or GAPDH.
Generation of TIPE2-Deficient Mice A 2.2 kb and a 5.0 kb TIPE2 genomic fragments were amplified by PCR and cloned into the Xhol/Nhe I and the Not I/SalI sites of the pOSDUPDEL vector (a gift from Dr. X-P Zhong, Duke University), respectively. TL1 embryonic stem cells from 129S6/SvEvTac mice were transfected with the targeting vector and subjected to positive and negative selection using G418 and ganciclovir, respectively. Two ES cell clones were identified by Southern blot, which had a copy of the TIPE2 gene (including both exons 1 and 2) replaced by the neomycin resistance gene cassette. The mutant ES cells were injected into 4-day-old C57BL/6J mouse blastocysts. The resultant chimeric male offsprings were crossed with 129S6/SvEvTac females for germline transmission. Unless indicated otherwise, all mice used in this study were of the 129S6/SvEvTac background. Age and sex matched littermates were used as controls. Mice were housed in the University of Pennsylvania Animal Care Facilities under pathogen-free conditions. All procedures used were preapproved by the Institutional Animal Care and Use Committee.
T Cell Cytokine and Proliferation Assays
Single cell suspensions of the lymph nodes and spleens were depleted of red blood cells using a hemolysis buffer. CD4 + T cells were then purified using the CD4 (L3T4) MicroBeads (Miltenyi Biotec) according to the manufacturer's protocol. Cells were cultured at a density of 1 3 10 6 per well in U-bottom 96-well plates in the presence of various concentrations of plate-bound anti-CD3 mAb and 2 mg/ml soluble anti-CD28 mAb. After 48 hr, the culture supernatants were collected and cytokine concentrations were determined by ELISA. For the proliferation assay, cells were cultured at 0.5 3 10 6 per well in the presence of the same antibodies described above, and pulsed with 3 H-thymidine (1 mCi/well) at 40 hr. Radioactivity was measured using a flat-bed beta counter (Beckman).
Activation-Induced Cell Death (AICD) and Cytokine Withdrawal-Induced Cell Death Splenocytes, 3 3 10 6 /well, were cultured for 48 hr in complete DMEM containing 20 U/ml IL-2 and 1 mg/ml anti-CD28 mAb in 48-well plates precoated with 1 mg/ml anti-CD3 mAb. For AICD assay, live cells were purified through a Ficoll density gradient and restimulated with plate-bound anti-CD3 mAb (10 mg/ml) for 24 hr. For cytokine withdrawal-induced cell death assay, live cells were cultured for 24 hr in complete DMEM containing no antibodies or exogenous cytokines. Cells were then stained with 7-AAD, annexin V, anti-CD4, and anti-CD8. The percentage of apoptotic cells was determined by flow cytometry.
Flow Cytometry
For cell surface markers, cells were stained with antibodies in PBS with 2% BSA and 0.05% sodium azide for 20 min at 4 C. For intracellular cytokines, cells were treated with Cytofix/Cytoperm kit and stained with anticytokine antibodies (BD Biosciences). After washing, cells were analyzed on a fourcolor FACS Calibur (BD Biosciences). Data analysis was performed using the CellQuest software.
TIPE2 Knockdown
TIPE2 siRNA (5 0 -GAAGTGAAACTCAGGTCCG-3 0 ) or scrambled control siRNA (5 0 -AGTGAAACAGTGCAGCTGC-3 0 ) was cloned into the lentiviral vector pLL3.7 that carries the green fluorescent protein (GFP) cDNA. Lentiviruses were produced by cotransfecting 293 T cells with the pLL3.7 plasmids and packaging vectors (Rubinson et al., 2003) . To knock down TIPE2 expression, RAW 264.7 or EL-4 cells were infected with recombinant lentiviruses that carry the TIPE2 siRNA. Cells infected with the same numbers of recombinant lentiviruses that carry the control siRNA serve as wild-type controls. GFP was used to track virus-infected cells. For the RAW 264.7 line, infected cells constitute more than 90% of the total, whereas for the EL-4 line, infected cells constitute $10% of the total. Analysis was performed on gated GFP + cells for the EL-4 line.
Statistical Analyses
The differences in protein and mRNA levels were analyzed by Student's t test.
The differences in survival rates were analyzed by Mann-Whitney U test.
ACCESSION NUMBERS
The GenBank accession number for the TIPE2 sequence reported in this paper is AF548004.
SUPPLEMENTAL DATA
Supplemental Data include 17 figures, Supplemental Experimental Procedures, and Supplemental References and can be found online at http:// www.cell.com/cgi/content/full/133/3/415/DC1/.
